Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.66 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.66 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.54 |
| ▸ | RELA | Q04206 | 1/20 | 0.54 |
| ▸ | FAAH | O00519 | 3/20 | 0.53 |
| ▸ | DGKA | P23743 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 4/20 | 0.45 |
| ▸ | TERT | O14746 | 3/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.45 |
| ▸ | PPARD | Q03181 | 3/20 | 0.45 |
| ▸ | PPARA | Q07869 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | BLM | P54132 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | FABP4 | P15090 | 2/20 | 0.45 |
| ▸ | GMNN | O75496 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8532124 | 0.92 | FFAR1 (0.60) | FFAR1FFAR4FAAHDGKAPPARG | |
| SCHEMBL8931485 | 0.89 | FFAR1 (0.65) | FFAR1FFAR4NFKB1NFKB2RELA | |
| SCHEMBL28020113 | 0.89 | FFAR1 (0.65) | FFAR1FFAR4NFKB1NFKB2RELA | |
| SCHEMBL11495230 | 0.87 | FFAR4 (0.61) | FFAR1FFAR4PPARGPTPN1PPARD | |
| SCHEMBL10425363 | 0.87 | FFAR4 (0.61) | FFAR1FFAR4PPARGPTPN1PPARD | |
| SCHEMBL11561334 | 0.87 | FFAR4 (0.61) | FFAR1FFAR4PPARGPTPN1PPARD | |
| SCHEMBL27484916 | 0.87 | FFAR4 (0.61) | FFAR1FFAR4PPARGPTPN1PPARD | |
| SCHEMBL10631927 | 0.87 | FFAR4 (0.61) | FFAR1FFAR4PPARGPTPN1PPARD | |
| SCHEMBL9443658 | 0.87 | FFAR4 (0.61) | FFAR1FFAR4PPARGPTPN1PPARD | |
| SCHEMBL8818527 | 0.87 | FFAR4 (0.61) | FFAR1FFAR4PPARGPTPN1PPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8278350-B2 | Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer | SHOWA DENKO K.K. (JP) | 2012-10-02 | — | — | US | disclosed |
| EP-1660025-B1 | COSMETIC COMPOSITION CONTAINING A POLYOXYETHYL COMBINATION AND A LIPOPEPTIDE | SHOWA DENKO KK (JP) | 2009-07-15 | — | — | EP | disclosed |
| US-20080311234-A1 | Oil-in-Water Emulsified Composition, and External Preparation for Skin and Cosmetics Using the Composition | SHOWA DENKO K.K. (JP) | 2008-12-18 | — | — | US | disclosed |
| US-20080234224-A1 | External Preparation For Skin | SHOWA DENKO K.K. (JP) | 2008-09-25 | — | — | US | disclosed |
| US-20070232687-A1 | Agent for Skin External Use Containing Tocopherol Derivative, Ascorbic Acid Derivative and Surface Active Agent Having Lipopeptide Structure | SHOWA DENKO K.K. (JP) | 2007-10-04 | — | — | US | disclosed |
| US-20070140998-A1 | Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer | SHOWA DENKO K.K. (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20060222616-A1 | Cosmetic composition comprising a and a lipopeptide | KANEKA CORPORATION (JP) | 2006-10-05 | — | — | US | disclosed |
| US-20050220744-A1 | Polysaccharide/functional compound complex | SHOWA DENKO K.K. | 2005-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070140998-A1 | Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer | CUTA, TTPA, RBP4 | FFAR1 34/4885FFAR4 22/4885NFKB1 490/4885 |
| US-20060222616-A1 | Cosmetic composition comprising a and a lipopeptide | CUTA, SMURF1, FABP4 | FFAR1 22/4885FFAR4 73/4885NFKB1 2801/4885 |
| US-20080311234-A1 | Oil-in-Water Emulsified Composition, and External Preparation for Skin and Cosmetics Using the Composition | CUTA, FPR1, FPR2 | FFAR1 16/4885FFAR4 108/4885NFKB1 2245/4885 |
| US-20070232687-A1 | Agent for Skin External Use Containing Tocopherol Derivative, Ascorbic Acid Derivative and Surface Active Agent Having Lipopeptide Structure | TTPA, GLA, CUTA | FFAR1 875/4885FFAR4 861/4885NFKB1 2815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.